Literature DB >> 30941469

Anabolic androgenic steroid dependence is associated with impaired emotion recognition.

Lisa E Hauger1, Dominic Sagoe2, Anja Vaskinn3, Espen A Arnevik4, Siri Leknes5, Marie L Jørstad4, Astrid Bjørnebekk4.   

Abstract

RATIONALE: Illicit use of anabolic androgenic steroids (AAS) has grown into a serious public health concern throughout the Western World. AAS use is associated with adverse medical, psychological, and social consequences. Around 30% of AAS users develop a dependence syndrome with sustained use despite adverse side effects. AAS dependence is associated with a high frequency of intra- and interpersonal problems, and it is central to identify factors related to the development and maintenance of dependence.
METHODS: The present study investigated the ability to recognize emotion from biological motion. The emotional biological motion task was administered to male AAS dependent users (AAS dependents; n = 45), AAS non-dependent users (AAS non-dependents; n = 38) and a comparison-group of non-using weightlifters (non-users; n = 69).
RESULTS: Multivariate analysis of variance showed a general impairment in emotion recognition in AAS dependents, compared to the non-using weightlifters, whereas no significant impairment was observed in AAS non-dependents. Furthermore, AAS dependents showed impaired recognition of fearful stimuli compared to both AAS non-dependents and non-using weightlifters. The between-group effect remained significant after controlling for Intelligence Quotient (IQ), past 6 months of non-AAS drug use, antisocial personality problems, anxiety, and depression.
CONCLUSION: AAS dependents show impaired emotion recognition from body movement, fear in particular, which could potentially contribute to higher frequency of interpersonal problems and antisocial behaviors in this population.

Entities:  

Keywords:  Anabolic androgenic steroids; Body language; Dependence; Emotion processing; Emotion recognition; Social cognition; Testosterone

Mesh:

Substances:

Year:  2019        PMID: 30941469     DOI: 10.1007/s00213-019-05239-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Anabolic-androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems.

Authors:  Bryan S Nelson; Tom Hildebrandt; Pascal Wallisch
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

2.  ADHD symptoms and use of anabolic androgenic steroids among male weightlifters.

Authors:  Emilie Kildal; Bjørnar Hassel; Astrid Bjørnebekk
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

3.  The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment.

Authors:  Ingrid Amalia Havnes; Marie Lindvik Jørstad; Jim McVeigh; Marie-Claire Van Hout; Astrid Bjørnebekk
Journal:  Subst Abuse       Date:  2020-02-18

4.  Theory of mind in users of anabolic androgenic steroids.

Authors:  Anja Vaskinn; Lisa E Hauger; Astrid Bjørnebekk
Journal:  Psychopharmacology (Berl)       Date:  2020-07-05       Impact factor: 4.530

Review 5.  Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review.

Authors:  Giuseppe Davide Albano; Francesco Amico; Giuseppe Cocimano; Aldo Liberto; Francesca Maglietta; Massimiliano Esposito; Giuseppe Li Rosi; Nunzio Di Nunno; Monica Salerno; Angelo Montana
Journal:  Healthcare (Basel)       Date:  2021-01-19

6.  Associations Between Anabolic-Androgenic Steroid Use and Sexual Health Behaviors Among Adolescent Boys: Results From the 2019 Youth Risk Behavior Survey.

Authors:  Kyle T Ganson; Dylan B Jackson; Alexander Testa; Pamela M Murnane; Jason M Nagata
Journal:  Am J Mens Health       Date:  2022 Jul-Aug

7.  Aggression and Psychological Distress in Male and Female Anabolic-Androgenic Steroid Users: A Multigroup Latent Class Analysis.

Authors:  Razieh Chegeni; Guy Notelaers; Ståle Pallesen; Dominic Sagoe
Journal:  Front Psychiatry       Date:  2021-06-04       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.